Actively Recruiting
Prediction of Recurrence and Complications of Nephrolithiasis Using a Precision Medicine Approach
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2023-02-08
2000
Participants Needed
1
Research Sites
524 weeks
Total Duration
On this page
Sponsors
C
Centre Hospitalier Universitaire, Amiens
Lead Sponsor
I
Institut Pasteur de Lille
Collaborating Sponsor
AI-Summary
What this Trial Is About
Nephrolithiasis is a disease caused by the formation of kidney stones in the urinary tract which can then partially or completely obstruct the latter causing an extremely sharp pain called renal colic. In industrialized countries, it affects 10 to 20% of the population, and is the most common kidney disease.The primary objective of this study is to identify the clinical, biological, genetic, molecular and environmental determinants predictive of recurrence of renal lithiasis. The study follow-up visit schedule corresponds to the visits usually scheduled as part of patient care: 1 year from the inclusion visit (A1), 3 years (A3) then 5 years (A5). Samples for research (additional volume of blood, urine) will be taken by a registered nurse along with the routine check-up samples.Samples intended for research will be sent by staff to the Biobanque de Picardie (CHU Amiens-Picardie) for processing and conservation.
CONDITIONS
Official Title
Prediction of Recurrence and Complications of Nephrolithiasis Using a Precision Medicine Approach
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years or older, male or female
- Able to understand and agree to the study information
- Affiliated with social security
- Agree to sign the informed consent form
- Have experienced at least one renal colic attack before joining the study
You will not qualify if you...
- Pregnant or breastfeeding women
- Persons deprived of liberty
- Adults under legal protection or unable to give consent
- Patients refusing to participate
- Patients in an emergency medical situation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Amiens Nord
Amiens, France, 80054
Actively Recruiting
Research Team
D
Dominique Eladari, Pr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here